news Celanese agrees to buy So.F.Ter
Celanese has agreed to acquire Italy-headquartered So.F.Ter Group, one of the world’s largest independent thermoplastic compounders. The deal, terms of which have not been disclosed, includes the full So.F.Ter product portfolio and all customer agreements and manufactur-
Clariant takes on fakers
Clariant joined with security specialist SICPA to launch the Plastiward anti-coun- terfeiting technology at CPhI Worldwide in Barce- lona in early October. Plastiward is described
as a “robust integrated protection for plastic pharmaceutical packaging or medical devices” and was devised to address growing demand for counterfeiting protection for plastic pharmaceutical packaging and devices for targeted delivery of treatments. According to Clariant,
Plastiward integrates exclusive, proprietary security features from SICPA into its masterbatch- es. Data gathered using a hand-held detector can be uploaded and aggregated on a secure inspection platform that enables real-time monitoring at global, regional or local level. ❙
www.clariant.com
6
ing, technology and commer- cial facilities.
The acquisition is expected
to close before the end of this year, until when the two will continue to operate indepen- dently.
The move will near double the number of Celanese’s global engineered materials
product platforms. Scott Sutton, EVP and President of the company’s Materials Solutions business, described it as “the next step in the evolution of Celanese to further extend our global leadership position in the engineered materials market”. Founded in 1980, So.F.Ter
Group originally made polymeric compounds for the shoe industry. It now employs about 550 at four manufactur- ing facilities in Italy and four more in Mexico, Brazil and the US, with a total of 55 produc- tion lines. ❙
www.softergroup.com ❙
www.celanese.com
Growth opportunity for OM
UK-based medical device maker Owen Mumford is developing a new variable dose Auto-injector to deliver an investigational growth hormone – Somavaratan - developed by US pharmaceutical maker Versartis.
The specific characteristics
of Somavaratan meant existing auto-injector designs were not suitable, said Owen Mumford Sales Manager Craig Thompson. “The team at Owen
Mumford has been able to provide balanced advice on the most appropriate methods for delivery of the formulation and
then collaborate with the Versartis team on the design,” he said.
Special features of the new design include variable dose setting, audible stop and start indication and live dosage delivery visualisation. The company said the new
device will be manufactured at Owen Mumford’s production site near Oxford in the UK. No date has yet been set for production start-up. ❙
www.owenmumford.com
$4m upgrade at National Door
US-based National Door Industries has completed a $4m expansion of its 14,000m2 manufacturing operation at Fort Worth in Texas, installing five new Engel moulding machines and automation. The company, which claims
to be the world’s largest manufacturer and distributor of garage door products, has installed five Engel machines ranging from 360 to 900 tonnes plus a Viper robot. The new equipment will be used to produce window frame parts
INJECTION WORLD | November/December 2016
and inserts. The investment has also included reconfiguration of its warehousing facilities, the
addition of new CNC machin- ing centres, and installation of a new water chilling system. ❙
www.natdoor.com
www.injectionworld.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66